Homozygous deletions of pl6/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood

Leukemia

Volumn 10, Issue 7, 1996, Pages 1104-1110

  Ohnishi, H ^a   Hanada, R ^b   Horibe, K ^c   Hongo, T ^d   Kawamura, M ^a   Naritaka, S ^a   Bessho, F ^a   Yanagisawa, M ^a   Nobori, T ^e   Yamamori, S ^f   Hayashi, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f Mitsubishi Kagaku Biochem Labs   (Japan)

Author keywords

Acute lymphoblastic leukemia; Childhood; E2a; p16; t(1; 19)

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILDHOOD LEUKEMIA; CODON; GENE DELETION; GENE REARRANGEMENT; HOMOZYGOSITY; HUMAN; HUMAN CELL; MISSENSE MUTATION; NONSENSE MUTATION; PRIORITY JOURNAL; ACUTE LYMPHOCYTIC LEUKEMIA; B CELL LEUKEMIA; CHILD; CHROMOSOME 1; CHROMOSOME 19; GENE TRANSLOCATION; GENETICS; HOMOZYGOTE; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

CARRIER PROTEIN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

BASE SEQUENCE; BLOTTING, SOUTHERN; CARRIER PROTEINS; CELL CYCLE PROTEINS; CHILD; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE DELETION; GENES, TUMOR SUPPRESSOR; HOMOZYGOTE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, PRE-B-CELL; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TRANSLOCATION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 0029666314     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Petty EM, Bale AE. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 1992; 258: 1148-1152.
2. Olopade OI, Jenkins RB, Ransom DT, Malik K, Pomykala H, Nobori T, Cowan JM, Rowley JD, Diaz MO. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 1992; 52: 2523-2529.
3. Olopade OI, Buchhagen DL, Malik K, Sherman J, Nobori T, Bader S, Nau MM, Gazdar AF, Minna JD, Diaz MO. Homozygous loss of the Interferon genes defines the critical region on 9p that is deleted in lung cancer. Cancer Res 1993; 53: 2410-2415.
4. Diaz MO, Rubin CM, Harden A, Ziemin S, Larson RA, LeBeau MM, Rowley JD. Deletions of interferon genes in acute lymphoblastic leukemia. N Engl J Med 1990; 322: 77-82.
5. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704-707.
6. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440.
7. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA, Deletions of cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753-756.
8. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994; 371: 257-261.
9. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC. Germline p16 mutations in familial melanoma. Nat Genet 1994; 8: 15-21.
10. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 1994; 54: 3396-3397.
11. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994; 265: 415-416.
12. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994; 8: 27-32.
13. Zang SY, Klein-Szanto AJP, Sauter ER, Shafarenko M, Matsunaga S, Nobori T, Carson DA, Ridge JA, Goodrow TL. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 1994; 54: 5050-5053.
14. ink4) in human breast carcinomas. Cancer Res 1994; 54: 5262-5264.
15. Giani C, Finocchiaro G. Mutational rate of the CDKN2 gene in malignant gliomas. Cancer Res 1994; 54: 6338-6339.
16. INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 1995; 85:2321-2330.
17. Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL, Bauters F, Wattel E, Fenaux P. p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 1995; 85: 657-663.
18. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res 1995; 55: 1448-1451.
19. Pullen DJ, Falletta JM, Crist WM, Volger LB, Dowell B, Humphrey GB, Blackstock R, van Eys J, Cooper MD, Metzgar RS, Meydrech EF. Southwest Oncology Group experience with immunological phenotyping in acute lymphoblastic leukemia of childhood. Cancer Res 1981; 41: 4802-4809.
20. Pui C-H, Brist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990; 76: 1449-1463.
21. Hayashi Y, Raimondi SC, Look AT. Molecular analysis of chromosomal abnormalities in childhood acute lymphoblastic leukemia. In: Kobayashi N, Akera S, Mizutani S (eds). Clinical Acute Leukemia: Present Problems and Future Prospects. Kluwer Academic Publishers: Boston, 1991, pp. 59-68.
22. Raimondi SC, Williams DL, Callihan T, Peiper S, Rivera GK, Murphy SB. Nonrandom involvement of the 12p12 breakpoint in chromosomal abnormalities of childhood acute lymphoblastic leukemia. Blood 1986; 68: 69-75.
23. Williams DL, Look AT, Melvin SL, Roberson PK, Dahl G, Flake T, Stass S. New chromsomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia. Cell 1984; 36: 101-109.
24. Hayashi Y, Raimondi SC, Look AT, Behm FG, Kitchingman GR, Pui C, Rivera GK, Williams DL. Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood 1991; 76: 1626-1630.
25. Fainstein E, Marcelle C, Rosner A, Canaani E, Gale RP, Dreazen O, Smith SD, Croce CM. A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukemia. Nature 1987; 330: 386-388.
26. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 1990; 60: 535-545.
27. Kamps MP, Murre C, Sun X-H, Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 1990; 60: 547-555.
28. Kawamura M, Kikuchi A, Kobayashi S, Hanada R, Yamamoto K, Horibe K, Shikano T, Ueda K, Hayashi K, Sekiya T, Hayashi Y. Mutations of the p53 and ras genes in childhood t(1;19) acute lymphoblastic leukemia. Blood 1995; 85: 2546-2552.
29. Sallan SE, Ritz J, Pesando J, Gelber R, O'Brien C, Hitchcock S, Coral F, Schlossman SF. Cell surface antigens. Prognostic implications in childhood acute lymphoblastic leukemia. Blood 1990; 55: 395-402.
30. Hayashi Y, Eguchi M, Sugita K, Nakazawa S, Sato T, Kojima S, Bessho F, Konishi S, Inaba T, Hanada R, Yamamoto K. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome. Blood 1988; 72: 15-23.
31. Kikuchi A, Hayashi Y, Kobayashi S, Hanada R, Moriwaki K, Yamamoto K, Fujimoto J, Kaneko Y, Yamamori S. Clinical significance of TAL1 gene alteration in childhood T-cell acyte lymphoblastic leukemia and lymphoma. Leukemia 1993; 7: 933-938.
32. Ohnishi H, Kawamura M, Ida K, Sheng X-M, Hanada R, Nobori T, Yamamori S, Hayashi Y. Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemias. Blood 1995; 86: 1269-1275.
33. Komuro H, Hayashi Y, Kawamura M, Hayashi K, Kaneko Y, Kamoshita S, Hanada R, Yamamoto K, Hongo T, Yamada M, Tsuchida Y. Mutations of p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res 1993; 53: 5284-5288.
34. Raimondi SC, Behm FG, Robertson PK, Williams DL, Pui C-H, Crist WM, Look AT, Ribersa GK. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol 1990; 8: 1380-1388.
35. Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, Hirai H. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 1994; 84: 2431-2435.
36. ink4) gene in cell lines established from children with acute lymphoblastic leukemia. Leukemia 1995; 9: 1159-1161.
37. INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood 1994; 84: 4038-4044.
38. Stranks G, Height SE, Mitchell P, Jadayel D, Yuille MAR, De Lord C, Clutterbuck RD, Treleaven JG, Powles RL, Nahceva E, Oscier DG, Karpas A, Lenoir GM, Smith SD, Millar JL, Catovsky D, Dyer MJS. Deletions and rearrangement of CDKN2 in lymphoid malignancies. Blood 1995; 85: 893-901.
39. Fizzotti M, Cimino G, Pisegna S, Alimena G, Quartarone C, Mandelli F, Pelicci PG, Coco FL. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood 1995; 85: 2685-2690.
40. INK4/MTS1) gene structure and expression in acute lymphoblastic leukemias. Leukemia 1995; 9: 1240-1245.
41. Spruck CH III, Gonzalez-Zulueta M, Shibata A, Simoneau AR, Lin M, Gonzales F, Tsai YC, Jones PA. p16 gene in uncultured tumors. Nature 1994; 370: 183-184.
42. Carrol AJ, Castleberry RP, Crist WM. Lack of association between abnormalities of the chromosome 9 short arm and either 'lymphomatous' features or T-cell phenotype in childhood acute lymphoblastic leukemia. Blood 1987; 69: 735-738.
43. Maseki N, Hayashi Y, Kaneko Y, Sakurai M. Partial loss of the short arm of chromosome 9 in leukemia and lymphoma. Cancer Genet Cytogenet 1986; 22: 89-90.